⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 1, 1987Journal of Clinical Oncology

CAF in metastatic breast cancer: standard therapy or another effective regimen?

D F Hayes I. Craig Henderson

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Article Tools Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.1987.5.10.1497 Journal of Clinical Oncology - published online before print September 22, 2016 PMID: 3309195 CAF in metastatic breast cancer: standard therapy or another effective regimen? D F HayesxD F HayesSearch for articles by this author , I C HendersonxI C HendersonSearch for articles by this author https://doi.org/10.1200/JCO.1987.5.10.1497 First Page PDF © 1987 by American Society of Clinical Oncology

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hayes et al. (1987) studied this question.

synapsesocial.com/papers/6a71d56ac2d7c30908272063 https://doi.org/10.1200/jco.1987.5.10.1497

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Image-Based Consensus Molecular Subtyping Refines Prognostication in Stage II/III Colorectal Cancer: A Retrospective Analysis of the SCOT TrialJournal of Clinical Oncology · 2026
2Per- and Polyfluoroalkyl Substance Exposure and Breast Cancer Incidence in the Sister StudyJournal of Clinical Oncology · 2026
3International Initiative on a Refined Staging System for Medullary Thyroid Cancer: A Multinational Multicenter StudyJournal of Clinical Oncology · 2026
4Circulating Tumor DNA Profiling Across Phase II/III Ewing Sarcoma Trials Identifies High-Risk Patients With TP53 , STAG2 , and CDKN2A AlterationsJournal of Clinical Oncology · 2026
5Feasibility and Tolerability of Chemoimmunotherapy Given During Induction for Treatment of Patients With High-Risk Neuroblastoma: A Report From the Children's Oncology GroupJournal of Clinical Oncology · 2026
6Stereotactic Ablative Radiotherapy Versus Surgical Resection for Early-Stage Non–Small Lung Cancer: An Emulated Target TrialJournal of Clinical Oncology · 2026
7Immunochemotherapy for Borderline Resectable or Locally Advanced Pancreatic Cancer: A Randomized Controlled TrialJournal of Clinical Oncology · 2026
8Methylphenidate for Hematologic Cancer–Related Fatigue: A Randomized Clinical TrialJournal of Clinical Oncology · 2026
9Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.4Journal of Clinical Oncology · 2026
10KEYNOTE-867: A Phase III, Randomized, Double-Blind Study of Stereotactic Body Radiotherapy With Pembrolizumab for Unresected Stage I or II Non–Small Cell Lung CancerJournal of Clinical Oncology · 2026

More from Journal of Clinical Oncology

More from Harvard University Press

More from Palmetto Hematology Oncology